ISPC (iSpecimen) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 26, 2026)


ISPC iSpecimen Inc ISPC
49 GF Score
Price $2.53
GF Value $6.72
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is iSpecimen Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

iSpecimen's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

ISPC vs FUNI, IVRO, BIAF: Margin of Safety % (DCF Earnings Based) Comparison

For the Diagnostics & Research subindustry, iSpecimen's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

iSpecimen Margin of Safety % (DCF Earnings Based) vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, iSpecimen's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where iSpecimen's Margin of Safety % (DCF Earnings Based) falls into.


ISPC
49GF Score
iSpecimen Inc ISPC
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is iSpecimen (ISPC) Overvalued in 2026?

Based on GuruFocus' analysis, iSpecimen stock appears to be undervalued. The current stock price of $2.53 is trading 62.4% below its estimated GF Value™ of $6.72. GuruFocus considers iSpecimen to be Possible Value Trap.

Key valuation signals for ISPC:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: $6.72 vs. price of $2.53 (62.4% below fair value)
  • GF Score™: 49/100 with 7 warning signs

No single metric tells the full story. See the ISPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

iSpecimen Business Description

Address 8 Cabot Road, Suite 1800, Woburn, MA, USA, 01801
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.
49GF Score

Get the complete analysis for ISPC

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.53
Price
$6.72
GF Value